# CoreWeave, Inc.: financial statements, quarterly CRWV · Nasdaq · CIK 1769628 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/crwv.md) · [Financials](/companies/crwv/financials.md) · [Filings](/companies/crwv/filings.md) · [Insiders](/companies/crwv/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crwv/financials.md?period=annual). ## Income statement | Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [189](/filings/0001769628-25-000014.md) | [395](/filings/0001769628-25-000041.md) | [584](/filings/0001769628-25-000062.md) | [747 d](/filings/0001769628-26-000104.md) | [982](/filings/0001769628-26-000222.md) | [1,212](/filings/0001769628-26-000366.md) | [1,365](/filings/0001769628-25-000062.md) | [1,572 d](/filings/0001769628-26-000104.md) | [2,078](/filings/0001769628-26-000222.md) | [2,575](/filings/0001769628-26-000366.md) | | Cost of revenue | $m | [59.2](/filings/0001769628-25-000014.md) | [109](/filings/0001769628-25-000041.md) | [143](/filings/0001769628-25-000062.md) | [182 d](/filings/0001769628-26-000104.md) | [262](/filings/0001769628-26-000222.md) | [313](/filings/0001769628-26-000366.md) | [369](/filings/0001769628-25-000062.md) | [509 d](/filings/0001769628-26-000104.md) | [716](/filings/0001769628-26-000222.md) | [879](/filings/0001769628-26-000366.md) | | Research and development | $m | [9.0](/filings/0001769628-25-000014.md) | [12.0](/filings/0001769628-25-000041.md) | [14.0](/filings/0001769628-25-000062.md) | [21.0 d](/filings/0001769628-26-000104.md) | [70.0](/filings/0001769628-26-000222.md) | [80.0](/filings/0001769628-26-000366.md) | [93.0](/filings/0001769628-25-000062.md) | [109 d](/filings/0001769628-26-000104.md) | [104](/filings/0001769628-26-000222.md) | [117](/filings/0001769628-26-000366.md) | | Operating income | $m | [16.8](/filings/0001769628-25-000014.md) | [77.7](/filings/0001769628-25-000041.md) | [117](/filings/0001769628-25-000062.md) | [112 d](/filings/0001769628-26-000104.md) | [(27.0)](/filings/0001769628-26-000222.md) | [19.0](/filings/0001769628-26-000366.md) | [51.9](/filings/0001769628-25-000062.md) | [(89.6) d](/filings/0001769628-26-000104.md) | [(144)](/filings/0001769628-26-000222.md) | [(49.0)](/filings/0001769628-26-000366.md) | | Income tax | $m | [15.4](/filings/0001769628-25-000014.md) | [40.2](/filings/0001769628-25-000041.md) | [41.7](/filings/0001769628-25-000062.md) | [21.8 d](/filings/0001769628-26-000104.md) | [46.0](/filings/0001769628-26-000222.md) | [48.0](/filings/0001769628-26-000366.md) | [(127)](/filings/0001769628-25-000062.md) | [(15.1) d](/filings/0001769628-26-000104.md) | [84.0](/filings/0001769628-26-000222.md) | [62.0](/filings/0001769628-26-000366.md) | | Net income | $m | [(129)](/filings/0001769628-25-000062.md) | [(323)](/filings/0001769628-25-000062.md) | [(360)](/filings/0001769628-25-000062.md) | [(50.9) d](/filings/0001769628-26-000104.md) | [(315)](/filings/0001769628-26-000366.md) | [(290)](/filings/0001769628-26-000366.md) | [(110)](/filings/0001769628-25-000062.md) | [(452) d](/filings/0001769628-26-000104.md) | [(740)](/filings/0001769628-26-000366.md) | [(626)](/filings/0001769628-26-000366.md) | | Diluted EPS | $ per share | [(0.62)](/filings/0001769628-25-000014.md) | [(1.62)](/filings/0001769628-25-000041.md) | [(1.82)](/filings/0001769628-25-000062.md) | not reported | [(1.49)](/filings/0001769628-26-000222.md) | [(0.60)](/filings/0001769628-26-000366.md) | [(0.22)](/filings/0001769628-25-000062.md) | not reported | [(1.40)](/filings/0001769628-26-000222.md) | [(1.14)](/filings/0001769628-26-000366.md) | | Basic EPS | $ per share | [(0.62)](/filings/0001769628-25-000014.md) | [(1.62)](/filings/0001769628-25-000041.md) | [(1.82)](/filings/0001769628-25-000062.md) | not reported | [(1.40)](/filings/0001769628-26-000222.md) | [(0.60)](/filings/0001769628-26-000366.md) | [(0.22)](/filings/0001769628-25-000062.md) | not reported | [(1.40)](/filings/0001769628-26-000222.md) | [(1.14)](/filings/0001769628-26-000366.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | not reported | [0.2](/filings/0001769628-26-000104.md) | [1.3](/filings/0001769628-25-000014.md) | [1.0](/filings/0001769628-25-000041.md) | [1.4](/filings/0001769628-25-000062.md) | [1.4](/filings/0001769628-26-000104.md) | [1.3](/filings/0001769628-26-000222.md) | [1.2](/filings/0001769628-26-000366.md) | [1.9](/filings/0001769628-25-000062.md) | [3.1](/filings/0001769628-26-000366.md) | [2.2](/filings/0001769628-26-000222.md) | [5.5](/filings/0001769628-26-000366.md) | | Current assets | $bn | not reported | not reported | not reported | not reported | not reported | [1.9](/filings/0001769628-26-000104.md) | [3.1](/filings/0001769628-25-000014.md) | [3.9](/filings/0001769628-25-000041.md) | [4.7](/filings/0001769628-25-000062.md) | [7.5](/filings/0001769628-26-000366.md) | [5.6](/filings/0001769628-26-000222.md) | [9.5](/filings/0001769628-26-000366.md) | | Total assets | $bn | not reported | not reported | not reported | not reported | not reported | [17.8](/filings/0001769628-26-000104.md) | [21.9](/filings/0001769628-25-000014.md) | [26.2](/filings/0001769628-25-000041.md) | [32.9](/filings/0001769628-25-000062.md) | [49.3](/filings/0001769628-26-000366.md) | [55.6](/filings/0001769628-26-000222.md) | [77.1](/filings/0001769628-26-000366.md) | | Current liabilities | $bn | not reported | not reported | not reported | not reported | not reported | [5.0](/filings/0001769628-26-000104.md) | [7.1](/filings/0001769628-25-000014.md) | [7.6](/filings/0001769628-25-000041.md) | [9.7](/filings/0001769628-25-000062.md) | [16.4](/filings/0001769628-26-000366.md) | [17.8](/filings/0001769628-26-000222.md) | [20.9](/filings/0001769628-26-000366.md) | | Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | [16.5](/filings/0001769628-26-000104.md) | [18.8](/filings/0001769628-25-000014.md) | [22.4](/filings/0001769628-25-000041.md) | [29.0](/filings/0001769628-25-000062.md) | [46.0](/filings/0001769628-26-000366.md) | [50.8](/filings/0001769628-26-000222.md) | [72.0](/filings/0001769628-26-000366.md) | | Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | [5.5](/filings/0001769628-26-000104.md) | [4.9](/filings/0001769628-25-000014.md) | [7.4](/filings/0001769628-25-000041.md) | [10.3](/filings/0001769628-25-000062.md) | [14.7](/filings/0001769628-26-000222.md) | [17.3](/filings/0001769628-26-000222.md) | not reported | | Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | [2.5](/filings/0001769628-26-000104.md) | [3.8](/filings/0001769628-25-000014.md) | [3.6](/filings/0001769628-25-000041.md) | [3.7](/filings/0001769628-25-000062.md) | [6.7](/filings/0001769628-26-000222.md) | [7.5](/filings/0001769628-26-000222.md) | not reported | | Shareholders' equity | $bn | [(0.0)](/filings/0001769628-26-000104.md) | [(0.6)](/filings/0001769628-26-000104.md) | [(0.7)](/filings/0001769628-25-000062.md) | [(1.0)](/filings/0001769628-25-000062.md) | [(0.3)](/filings/0001769628-25-000062.md) | [(0.4)](/filings/0001769628-26-000366.md) | [1.9](/filings/0001769628-26-000366.md) | [2.7](/filings/0001769628-26-000366.md) | [3.9](/filings/0001769628-25-000062.md) | [3.3](/filings/0001769628-26-000366.md) | [4.8](/filings/0001769628-26-000366.md) | [5.0](/filings/0001769628-26-000366.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [2,039](/filings/0001769628-25-000014.md) | [(118) d](/filings/0001769628-25-000041.md) | [641 d](/filings/0001769628-25-000062.md) | [187 d](/filings/0001769628-26-000104.md) | [61.0](/filings/0001769628-26-000222.md) | [(251) d](/filings/0001769628-26-000366.md) | [1,689 d](/filings/0001769628-25-000062.md) | [1,559 d](/filings/0001769628-26-000104.md) | [2,984](/filings/0001769628-26-000222.md) | [679 d](/filings/0001769628-26-000366.md) | | Capital expenditure | $m | [1,742](/filings/0001769628-25-000014.md) | [2,247 d](/filings/0001769628-25-000041.md) | [1,215 d](/filings/0001769628-25-000062.md) | [3,498 d](/filings/0001769628-26-000104.md) | [1,407](/filings/0001769628-26-000222.md) | [2,453 d](/filings/0001769628-26-000366.md) | [2,389 d](/filings/0001769628-25-000062.md) | [4,060 d](/filings/0001769628-26-000104.md) | [7,695](/filings/0001769628-26-000222.md) | [6,422 d](/filings/0001769628-26-000366.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [209](/filings/0001769628-25-000014.md) | [210](/filings/0001769628-25-000041.md) | [214](/filings/0001769628-25-000062.md) | [249](/filings/0001769628-26-000222.md) | [487](/filings/0001769628-26-000366.md) | [498](/filings/0001769628-25-000062.md) | [527](/filings/0001769628-26-000222.md) | [551](/filings/0001769628-26-000366.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.